January 22nd, 2021
•This workflow can be used to perform antibiotic susceptibility testing using an established ex vivo model of bacterial biofilm in the lungs of individuals with cystic fibrosis. Use of this model could enhance the clinical validity of MBEC (minimal biofilm eradication concentration) assays.
Tags
Vídeos Relacionados
Co-culture Models of Pseudomonas aeruginosa Biofilms Grown on Live Human Airway Cells
Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
Experimental Endocarditis Model of Methicillin Resistant Staphylococcus aureus (MRSA) in Rat
Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice
Pseudomonas aeruginosa Induced Lung Injury Model
Studying Microbial Communities In Vivo: A Model of Host-mediated Interaction Between Candida Albicans and Pseudomonas Aeruginosa in the Airways
Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa
An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
Come to the Light Side: In Vivo Monitoring of Pseudomonas aeruginosa Biofilm Infections in Chronic Wounds in a Diabetic Hairless Murine Model
A Mouse Model to Assess Innate Immune Response to Staphylococcus aureus Infection
SOBRE A JoVE
Copyright © 2024 MyJoVE Corporation. Todos os direitos reservados